|
1
|
Dinarello CA: A clinical perspective of
IL-1β as the gatekeeper of inflammation. Eur J Immunol.
41:1203–1217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li L, Fei Z, Ren J, Sun R, Liu Z, Sheng Z,
Wang L, Sun X, Yu J, Wang Z, et al: Functional imaging of
interleukin 1 beta expression in inflammatory process using
bioluminescence imaging in transgenic mice. BMC Immunol. 9:492008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allan SM, Tyrrell PJ and Rothwell NJ:
Interleukin-1 and neuronal injury. Nat Rev Immunol. 5:629–640.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cappellano G, Carecchio M, Fleetwood T,
Magistrelli L, Cantello R, Dianzani U and Comi C: Immunity and
inflammation in neurodegenerative diseases. Am J Neurodegener Dis.
2:89–107. 2013.PubMed/NCBI
|
|
5
|
Lu X, Ma L, Ruan L, Kong Y, Mou H, Zhang
Z, Wang Z, Wang JM and Le Y: Resveratrol differentially modulates
inflammatory responses of microglia and astrocytes. J
Neuroinflammation. 7:462010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sheng JG, Bora SH, Xu G, Borchelt DR,
Price DL and Koliatsos VE:
Lipopolysaccharide-induced-neuroinflammation increases
intracellular accumulation of amyloid precursor protein and amyloid
beta peptide in APPswe transgenic mice. Neurobiol Dis. 14:133–145.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cassel SL, Joly S and Sutterwala FS: The
NLRP3 inflammasome: A sensor of immune danger signals. Semin
Immunol. 21:194–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Nardo D and Latz E: NLRP3 inflammasomes
link inflammation and metabolic disease. Trends Immunol.
32:373–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Englezou PC, Rothwell SW, Ainscough JS,
Brough D, Landsiedel R, Verkhratsky A, Kimber I and Dearman RJ:
P2X7R activation drives distinct IL-1 responses in dendritic cells
compared to macrophages. Cytokine. 74:293–304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mariathasan S, Weiss DS, Newton K, McBride
J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and
Dixit VM: Cryopyrin activates the inflammasome in response to
toxins and ATP. Nature. 440:228–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schroder K, Zhou R and Tschopp J: The
NLRP3 inflammasome: A sensor for metabolic danger? Science.
327:296–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferrari D, Pizzirani C, Adinolfi E, Lemoli
RM, Curti A, Idzko M, Panther E and Di Virgilio F: The P2X7
receptor: A key player in IL-1 processing and release. J Immunol.
176:3877–3883. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lam TK, Gallicchio L, Lindsley K, Shiels
M, Hammond E, Tao XG, Chen L, Robinson KA, Caulfield LE, Herman JG,
et al: Cruciferous vegetable consumption and lung cancer risk: A
systematic review. Cancer Epidemiol Biomarkers Prev. 18:184–195.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang L, Paonessa JD, Zhang Y, Ambrosone CB
and McCann SE: Total isothiocyanate yield from raw cruciferous
vegetables commonly consumed in the United States. J Funct Foods.
5:1996–2001. 2013. View Article : Google Scholar
|
|
15
|
Wu X, Zhou QH and Xu K: Are
isothiocyanates potential anticancer drugs? Acta Pharmacol Sin.
30:501–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee Y, Kim YJ, Choi YJ, Lee JW, Lee S and
Chung HW: Enhancement of cisplatin cytotoxicity by benzyl
isothiocyanate in HL-60 cells. Food Chem Toxicol. 50:2397–2406.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS,
Wu SH and Chung JG: Benzyl isothiocyanate (BITC) inhibits migration
and invasion of human colon cancer HT29 cells by inhibiting matrix
metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC
and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee YM, Seon MR, Cho HJ, Kim JS and Park
JH: Benzyl isothiocyanate exhibits anti-inflammatory effects in
murine macrophages and in mouse skin. J Mol Med Berl. 87:1251–1261.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bauernfeind FG, Horvath G, Stutz A,
Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks
BG, Fitzgerald KA, et al: Cutting edge: NF-kappaB activating
pattern recognition and cytokine receptors license NLRP3
inflammasome activation by regulating NLRP3 expression. J Immunol.
183:787–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hagberg H, Mallard C, Ferriero DM,
Vannucci SJ, Levison SW, Vexler ZS and Gressens P: The role of
inflammation in perinatal brain injury. Nat Rev Neurol. 11:192–208.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Rivero Vaccari JP, Dietrich WD and
Keane RW: Therapeutics targeting the inflammasome after central
nervous system injury. Transl Res. 167:35–45. 2016. View Article : Google Scholar
|
|
22
|
Jung WK, Lee DY, Park C, Choi YH, Choi I,
Park SG, Seo SK, Lee SW, Yea SS, Ahn SC, et al: Cilostazol is
anti-inflammatory in BV2 microglial cells by inactivating nuclear
factor-kappaB and inhibiting mitogen-activated protein kinases. Br
J Pharmacol. 159:1274–1285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McGeer PL and McGeer EG: The inflammatory
response system of brain: Implications for therapy of Alzheimer and
other neurodegenerative diseases. Brain Res Brain Res Rev.
21:195–218. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
González-Scarano F and Baltuch G:
Microglia as mediators of inflammatory and degenerative diseases.
Annu Rev Neurosci. 22:219–240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu B and Hong JS: Role of microglia in
inflammation-mediated neurodegenerative diseases: Mechanisms and
strategies for therapeutic intervention. J Pharmacol Exp Ther.
304:1–7. 2003. View Article : Google Scholar
|
|
26
|
Eikelenboom P and van Gool WA:
Neuroinflammatory perspectives on the two faces of Alzheimer's
disease. J Neural Transm Vienna. 111:281–294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pascual-Lucas M, Fernandez-Lizarbe S,
Montesinos J and Guerri C: LPS or ethanol triggers clathrin- and
rafts/caveolae-dependent endocytosis of TLR4 in cortical
astrocytes. J Neurochem. 129:448–462. 2014. View Article : Google Scholar
|
|
28
|
Min KJ, Choi K and Kwon TK: Withaferin A
down-regulates lipopolysaccharide-induced cyclooxygenase-2
expression and PGE2 production through the inhibition of
STAT1/3 activation in microglial cells. Int Immunopharmacol.
11:1137–1142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lull ME and Block ML: Microglial
activation and chronic neurodegeneration. Neurotherapeutics.
7:354–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Franchi L, Eigenbrod T and Núñez G:
Cutting edge: TNF-alpha mediates sensitization to ATP and silica
via the NLRP3 inflammasome in the absence of microbial stimulation.
J Immunol. 183:792–796. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sperlágh B and Illes P: P2X7 receptor: An
emerging target in central nervous system diseases. Trends
Pharmacol Sci. 35:537–547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi AJ and Ryter SW: Inflammasomes:
Molecular regulation and implications for metabolic and cognitive
diseases. Mol Cells. 37:441–448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mariathasan S and Monack DM: Inflammasome
adaptors and sensors: Intracellular regulators of infection and
inflammation. Nat Rev Immunol. 7:31–40. 2007. View Article : Google Scholar
|
|
34
|
Guo H, Callaway JB and Ting JP:
Inflammasomes: Mechanism of action, role in disease, and
therapeutics. Nat Med. 21:677–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martinon F: Signaling by ROS drives
inflammasome activation. Eur J Immunol. 40:616–619. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tschopp J and Schroder K: NLRP3
inflammasome activation: The convergence of multiple signalling
pathways on ROS production? Nat Rev Immunol. 10:210–215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fay AJ, Qian X, Jan YN and Jan LY: SK
channels mediate NADPH oxidase-independent reactive oxygen species
production and apoptosis in granulocytes. Proc Natl Acad Sci USA.
103:17548–17553. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar
|
|
39
|
Wen H, Gris D, Lei Y, Jha S, Zhang L,
Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3-ASC
inflammasome activation interferes with insulin signaling. Nat
Immunol. 12:408–415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakahira K, Haspel JA, Rathinam VA, Lee
SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim
HP, et al: Autophagy proteins regulate innate immune responses by
inhibiting the release of mitochondrial DNA mediated by the NALP3
inflammasome. Nat Immunol. 12:222–230. 2011. View Article : Google Scholar
|
|
41
|
Budai MM, Varga A, Milesz S, Tőzsér J and
Benkő S: Aloe vera downregulates LPS-induced inflammatory cytokine
production and expression of NLRP3 inflammasome in human
macrophages. Mol Immunol. 56:471–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang F, Qian L, Flood PM, Shi JS, Hong JS
and Gao HM: Inhibition of IkappaB kinase-beta protects dopamine
neurons against lipopolysaccharide-induced neurotoxicity. J
Pharmacol Exp Ther. 333:822–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hang CH, Shi JX, Tian J, Li JS, Wu W and
Yin HX: Effect of systemic LPS injection on cortical NF-kappaB
activity and inflammatory response following traumatic brain injury
in rats. Brain Res. 1026:23–32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Land WG: Transfusion-related acute lung
injury: The work of DAMPs. Transfus Med Hemother. 40:3–13. 2013.
View Article : Google Scholar : PubMed/NCBI
|
